Antipsychotic AgentsClozapineRisperidonePerphenazineSchizophreniaDibenzothiazepinesBenzodiazepinesHaloperidolDyskinesia, Drug-InducedTreatment OutcomeBasal Ganglia DiseasesPsychotic DisordersPsychotropic DrugsOff-Label UseSulpirideSchizophrenic PsychologyReceptors, Dopamine D2FluphenazinePirenzepineAkathisia, Drug-InducedCatalepsyPolypharmacySchizophrenia, ParanoidDopamine AntagonistsReceptor, Serotonin, 5-HT2AChlorpromazineDrug SubstitutionBrief Psychiatric Rating ScalePhenothiazinesPsychomotor AgitationBipolar DisorderPiperazinesPsychiatric Status Rating ScalesThioridazineApomorphineReceptors, Dopamine D3Startle ReactionAntidepressive AgentsRemoxiprideWeight GainQuinolonesPharmacovigilancePerazineThiazolesMental DisordersDrug CostsAntimanic AgentsPharmacoepidemiologyHyperprolactinemiaLithium CarbonateBiperidenDrug UtilizationPharmacogeneticsPimozideDopamine AgonistsClopenthixolGalactorrheaAlgeriaTherapeutic EquipoiseLoxapinePhencyclidineReceptors, DopamineNursing HomesSerotonin AntagonistsIsoxazolesReceptors, Serotonin, 5-HT2CroatiaReceptors, SerotoninDelayed-Action PreparationsDementiaDrug PrescriptionsNeuroleptic Malignant SyndromeDrug Utilization ReviewDrug Therapy, CombinationCholinergic AntagonistsPsychiatryPenfluridolIsoindolesRandomized Controlled Trials as TopicDose-Response Relationship, DrugFluspirileneCentral Nervous System Agents